MedTrace Logo

Detecting Systemic Carbon Dioxide Levels With a Novel Biosensor

NCT06367686 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2025-03-26

No results posted yet for this study

Summary

The study is an open, prospective, single center clinical observational pilot investigation. The aim is to compare the carbon dioxide values measured by the IscAlert sensor, which is inserted in proximity to the nasal mucosa. The study wants to investigate if the nasal mucosa application and measurements are feasible, what kind of possible complications such a measurement can cause, and if the measurements can be a surrogate marker for systemic carbon dioxide values.

Conditions

  • Hypercapnic Respiratory Failure
  • Pulmonary Disease, Chronic Obstructive
  • Neuromuscular Diseases
  • Obesity Hypoventilation Syndrome (OHS)

Interventions

DEVICE

IscAlert sensor

Insertion of an IscAlert sensor at the nasal mucosa

Sponsors & Collaborators

  • Sensocure AS

    collaborator INDUSTRY

  • The Hospital of Vestfold

    lead OTHER

Principal Investigators

  • Anne-Marie Gabrielsen, MD, PhD · The Hospital of Vestfold

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-30
Primary Completion
2025-10-30
Completion
2026-06-19

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06367686 on ClinicalTrials.gov